Bipartisan House Bill Introduced To Curb FDA Health IT Oversight
This article was originally published in The Pink Sheet Daily
The SOFTWARE Act, introduced in the House by Rep. Marsha Blackburn, R-Tenn., with support from House members on both sides of the aisle, attempts to redefine regulation of health information technology, and, in particular, limit FDA’s oversight to “products that pose a potential risk to human health.”
You may also be interested in...
In a long-awaited final guidance, FDA affirmed its plan to practice enforcement discretion for most mobile medical apps, except those applications that present the same risks as conventional FDA-regulated devices. Some digital health stakeholders praised the guidance, while others wished FDA has waited.
An impassioned debate brewing about FDA’s planned timing for finalizing mobile medical apps guidance bubbled to the surface at a recent meeting of the HHS workgroup tasked with recommending a health IT regulatory framework. Despite pressure to delay the guidance, FDA says it is still pushing ahead.
Draft legislation obtained by “The Gray Sheet” that seeks to restrain FDA’s oversight of mobile apps is being circulated for stakeholder comment by Rep. Marsha Blackburn, R-Tenn., and colleagues.